These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 11903525)

  • 1. Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache.
    Edwards KR; Norton J; Behnke M
    Headache; 2001; 41(10):976-80. PubMed ID: 11903525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized open-label study of sodium valproate vs sumatriptan and metoclopramide for prolonged migraine headache.
    Bakhshayesh B; Seyed Saadat SM; Rezania K; Hatamian H; Hossieninezhad M
    Am J Emerg Med; 2013 Mar; 31(3):540-4. PubMed ID: 23380105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Calcium carbasalate-metoclopramide combination versus dihydroergotamine in the treatment of migraine attacks].
    Pradalier A; Guérard des Lauriers A; Scheck F; Peraudeau P; Lacoste JP; Cajfinger F
    Pathol Biol (Paris); 1995 Nov; 43(9):806-13. PubMed ID: 8746103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine.
    Winner P; Ricalde O; Le Force B; Saper J; Margul B
    Arch Neurol; 1996 Feb; 53(2):180-4. PubMed ID: 8639069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous valproate sodium in the treatment of daily headache.
    Schwartz TH; Karpitskiy VV; Sohn RS
    Headache; 2002 Jun; 42(6):519-22. PubMed ID: 12167141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine.
    Aurora SK; Silberstein SD; Kori SH; Tepper SJ; Borland SW; Wang M; Dodick DW
    Headache; 2011 Apr; 51(4):507-17. PubMed ID: 21457235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache.
    Carleton SC; Shesser RF; Pietrzak MP; Chudnofsky CR; Starkman S; Morris DL; Johnson G; Rhee KJ; Barton CW; Chelly JE; Rosenberg J; Van Valen MK
    Ann Emerg Med; 1998 Aug; 32(2):129-38. PubMed ID: 9701293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of intravenous valproate with intravenous lysine-acetylsalicylic acid in acute migraine attacks.
    Leniger T; Pageler L; Stude P; Diener HC; Limmroth V
    Headache; 2005 Jan; 45(1):42-6. PubMed ID: 15663612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report.
    Mathew NT; Kailasam J; Meadors L; Chernyschev O; Gentry P
    Headache; 2000 Oct; 40(9):720-3. PubMed ID: 11091289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous Valproate versus Subcutaneous Sumatriptan in Acute Migraine Attack.
    Ghaderibarmi F; Tavakkoli N; Togha M
    Acta Med Iran; 2015 Oct; 53(10):633-6. PubMed ID: 26615376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of primary headache disorders with intravenous valproate: initial outpatient experience.
    Stillman MJ; Zajac D; Rybicki LA
    Headache; 2004 Jan; 44(1):65-9. PubMed ID: 14979885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current emergency treatment of severe migraine headaches.
    Klapper JA; Stanton J
    Headache; 1993; 33(10):560-2. PubMed ID: 8294195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diphenhydramine as Adjuvant Therapy for Acute Migraine: An Emergency Department-Based Randomized Clinical Trial.
    Friedman BW; Cabral L; Adewunmi V; Solorzano C; Esses D; Bijur PE; Gallagher EJ
    Ann Emerg Med; 2016 Jan; 67(1):32-39.e3. PubMed ID: 26320523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravenous sodium valproate vs dexamethasone on acute migraine headache: a double blind randomized clinical trial.
    Mazaheri S; Poorolajal J; Hosseinzadeh A; Fazlian MM
    PLoS One; 2015; 10(3):e0120229. PubMed ID: 25793707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache.
    Swidan SZ; Lake AE; Saper JR
    Curr Pain Headache Rep; 2005 Feb; 9(1):65-70. PubMed ID: 15625028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosing and administration of ergotamine tartrate and dihydroergotamine.
    Mathew NT
    Headache; 1997; 37 Suppl 1():S26-32. PubMed ID: 9009471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydroergotamine for early and late treatment of migraine with cutaneous allodynia: an open-label pilot trial.
    Silberstein SD; Young WB; Hopkins MM; Gebeline-Myers C; Bradley KC
    Headache; 2007 Jun; 47(6):878-85. PubMed ID: 17578539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sumatriptan. An updated review of its use in migraine.
    Perry CM; Markham A
    Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of IV valproate vs metoclopramide vs ketorolac for acute migraine.
    Friedman BW; Garber L; Yoon A; Solorzano C; Wollowitz A; Esses D; Bijur PE; Gallagher EJ
    Neurology; 2014 Mar; 82(11):976-83. PubMed ID: 24523483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute treatment of migraine with dihydroergotamine nasal spray. Dihydroergotamine Working Group.
    Gallagher RM
    Arch Neurol; 1996 Dec; 53(12):1285-91. PubMed ID: 8970458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.